Revenue: The sum of all revenue fields included for a company's operating activities.
Lineage Cell Therapeutics, Inc. (LCTX) had Revenue of $3.68M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
|
Revenue |
$3.68M |
$-29.78M |
|
$0.01M |
|
$3.68M |
|
$7.47M |
|
$-3.79M |
|
$-25.97M |
|
$-29.75M |
|
$-29.75M |
|
$-29.75M |
|
$-29.75M |
|
$-29.75M |
|
$-29.75M |
|
$-3.79M |
|
$-3.56M |
|
228.85M |
|
228.85M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$42.26M |
|
$2.16M |
|
$47.38M |
|
$89.64M |
|
$9.38M |
|
$0.04M |
|
$59.46M |
|
$68.84M |
|
$20.80M |
|
$-21.58M |
|
$20.80M |
|
230.33M |
|
| Cash Flow Statement Financials | |
$-14.04M |
|
$1.88M |
|
$6.57M |
|
$46.35M |
|
$40.98M |
|
$-5.38M |
|
$3.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.50 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
99.86% |
|
-102.85% |
|
-102.85% |
|
-- |
|
-808.26% |
|
-809.05% |
|
$-14.16M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
28.98 |
|
3.11 |
|
-143.07% |
|
137.89% |
|
-33.19% |
|
-142.79% |
|
$0.09 |
|
$-0.06 |
|
$-0.06 |
|